Class Action Lawsuit Announced by Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. has recently initiated a class action lawsuit concerning trading irregularities at uniQure N.V. The lawsuit, filed in the United States District Court for the Southern District of New York, targets individuals and entities that purchased or acquired uniQure ordinary shares between September 24, 2025, and October 31, 2025. The Class Period runs inclusive of these dates, granting affected investors until April 13, 2026, to seek appointment as lead plaintiff in the case.
According to the allegations outlined in the complaint, the defendants are accused of issuing false or misleading statements during the Class Period regarding uniQure’s business activities. Specifically, it is claimed that the design of uniQure’s Pivotal Study, as well as comparisons with the ENROLL-HD external historical data set, did not receive full FDA approval. Furthermore, the defendants allegedly minimized the likelihood of any delays to uniQure’s BLA timeline, despite the need for additional studies to complement the BLA submission following the study’s purported success. As a result, the defendants’ statements regarding the Company’s business, operations, and future potential were found to be lacking a reasonable foundation.
Affected parties who have experienced losses due to their involvement with uniQure during the specified time frame are encouraged to contact Bragar Eagel & Squire, P.C. As a nationally recognized legal firm with branches in New York, South Carolina, and California, Bragar Eagel & Squire, P.C. specializes in representing individual and institutional investors in securities, derivative, and commercial litigation matters, as well as clients involved in consumer protection and data privacy disputes. They operate on a national scale, handling cases in both federal and state courts.
The significance of this lawsuit indicates potential irregularities within uniQure N.V. that could have negatively impacted investors during the timeline specified in the Class Period. Investors who suffered financial losses as a result of their connection with uniQure are advised to seek legal counsel to explore their rights and possible courses of action. The opportunity to address any concerns related to this matter is available to impacted parties through the contact information provided by Bragar Eagel & Squire, P.C.
In conclusion, the class action lawsuit against uniQure N.V. signifies a significant legal endeavor to address alleged misrepresentations and omissions by the defendants regarding the Company’s operational aspects during the Class Period. Investors affected by these actions are urged to contact legal counsel promptly to discuss potential avenues for recourse and to address any questions or concerns related to this lawsuit.